Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

(HZNP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 3 2756 78016 14522 355--
Entreprise Value (EV)1 4 2137 05715 06823 45222 12020 530
P/E ratio -12,5x40,4x53,9x21,8x-
Yield ------
Capitalization / Revenue 2,71x5,22x7,34x7,00x5,62x4,91x
EV / Revenue 3,49x5,43x6,85x7,34x5,56x4,51x
EV / EBITDA 9,33x14,6x15,1x17,4x12,6x9,67x
Price to Book 3,13x3,89x-5,09x4,27x3,47x
Nbr of stocks (in thousands) 167 626187 302220 710226 821--
Reference price (USD) 19,536,273,298,698,698,6
Announcement Date 02/27/201902/26/202002/24/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 1 2081 3002 2003 1963 9764 556
EBITDA1 4514839991 3471 7572 123
Operating profit (EBIT)1 4504819961 3411 7772 166
Operating Margin 37,3%37,0%45,2%42,0%44,7%47,6%
Pre-Tax Profit (EBT)1 -119-20,24021 2511 6362 019
Net income1 -5733904311 079-
Net margin -44,1%17,7%13,5%27,1%-
EPS2 -2,901,811,834,53-
Dividend per Share2 ------
Announcement Date 02/27/201902/26/202002/24/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 3428331 037994899961
EBITDA1 45,8367509429--
Operating profit (EBIT)1 43,7368510429358411
Operating Margin 12,8%44,2%49,2%43,1%39,9%42,8%
Pre-Tax Profit (EBT)1 --307394344409
Net income1 -12315832769,6--
Net margin -36,0%19,0%31,5%7,01%--
EPS2 -0,550,671,380,29--
Dividend per Share ------
Announcement Date 05/05/202108/04/202111/03/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 938277-1 097--
Net Cash position1 --1 077-2361 826
Leverage (Debt / EBITDA) 2,08x0,57x-1,08x0,81x-0,13x-0,86x
Free Cash Flow1 1904083868841 6541 971
ROE (Net Profit / Equities) 30,6%23,1%27,6%27,8%26,7%25,2%
Shareholders' equity1 -2 4781 4111 5534 048-
ROA (Net Profit / Asset) --16,3%15,2%15,3%15,6%
Assets1 --2 3882 8427 069-
Book Value Per Share2 6,249,32-19,423,128,4
Cash Flow per Share2 -2,082,584,977,09-
Capex1 4,7717,917027,928,730,2
Capex / Sales 0,40%1,37%7,72%0,87%0,72%0,66%
Announcement Date 02/27/201902/26/202002/24/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 22 355 479 139
Net sales (USD) 2 200 429 000
Number of employees 1 805
Sales / Employee (USD) 1 219 074
Free-Float 98,0%
Free-Float capitalization (USD) 21 905 378 657
Avg. Exchange 20 sessions (USD) 169 510 870
Average Daily Capital Traded 0,76%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA